Axogen, Inc. announced the appointment of Jesse Bishop as Vice President of Regulatory Affairs, effective February 3, 2025. Mr. Bishop will report to Michael Dale, President and Chief Executive Officer.
In this role, Mr. Bishop will be responsible for leading the development and execution of domestic and international regulatory strategies. His focus will be on advancing company objectives related to product approvals and compliance.
This appointment strengthens Axogen's regulatory leadership at a critical time, especially as the company progresses through the Biologics License Application process for its Avance Nerve Graft. Effective regulatory management is crucial for market access and commercial success.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.